APA

Obermannova R., Valik D., Hasenclever D., Zdrazilova-Dubska L., Hacker U., Demlova R., Selingerova I. & Lordick F. (20200601). High prevalence of severe hypovitaminosis D in patients with advanced gastric cancer treated with first-line chemotherapy with or without anti-EGFR-directed monoclonal antibody (EXPAND trial) showing no prognostic impact. : European journal of cancer (Oxford, England : 1990).

Chicago

Obermannova Radka, Valik Dalibor, Hasenclever Dirk, Zdrazilova-Dubska Lenka, Hacker Ulrich, Demlova Regina, Selingerova Iveta and Lordick Florian. 20200601. High prevalence of severe hypovitaminosis D in patients with advanced gastric cancer treated with first-line chemotherapy with or without anti-EGFR-directed monoclonal antibody (EXPAND trial) showing no prognostic impact. : European journal of cancer (Oxford, England : 1990).

Harvard

Obermannova R., Valik D., Hasenclever D., Zdrazilova-Dubska L., Hacker U., Demlova R., Selingerova I. and Lordick F. (20200601). High prevalence of severe hypovitaminosis D in patients with advanced gastric cancer treated with first-line chemotherapy with or without anti-EGFR-directed monoclonal antibody (EXPAND trial) showing no prognostic impact. : European journal of cancer (Oxford, England : 1990).

MLA

Obermannova Radka, Valik Dalibor, Hasenclever Dirk, Zdrazilova-Dubska Lenka, Hacker Ulrich, Demlova Regina, Selingerova Iveta and Lordick Florian. High prevalence of severe hypovitaminosis D in patients with advanced gastric cancer treated with first-line chemotherapy with or without anti-EGFR-directed monoclonal antibody (EXPAND trial) showing no prognostic impact. : European journal of cancer (Oxford, England : 1990). 20200601.